share_log

Baird Maintains Outperform on Boston Scientific, Raises Price Target to $84

Benzinga ·  Apr 25 06:43

Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $79 to $84.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment